Reduced CD74 expression on neutrophils significantly impairs the anti-tumor function of T cells, whereas high CD74 expression promotes an anti-tumor immune microenvironment and may synergize with immunotherapy to enhance tumor suppression. Here, CD74 is linked to neoplasm.